3D Global Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	66.53	91.7	-57.95	-67.09	-59.71
Depreciation & Amortization	27.65	21.82	22.74	25.58	24.59
Other Amortization	-	0.02	0.15	0.29	0.29
Loss (Gain) From Sale of Assets	-	-0	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	18.89	-
Stock-Based Compensation	3.16	4.21	0.12	0.28	0.6
Provision & Write-off of Bad Debts	2.77	0.21	-	-	-
Other Operating Activities	-14.1	3.1	-0.98	-16.08	-1
Change in Accounts Receivable	44.76	-118.41	-0.25	0.14	0.42
Change in Inventory	-15.34	-3.45	-0.23	-2.49	0.26
Change in Accounts Payable	-13.32	12.75	1.11	1.56	-0.26
Change in Unearned Revenue	7.77	-0.68	5.09	1.51	-
Change in Other Net Operating Assets	1.02	8.38	-1.42	2.93	-1.18
Operating Cash Flow	110.91	19.65	-31.61	-34.49	-35.99
Operating Cash Flow Growth	464.34%	-	-	-	-
Capital Expenditures	-6.16	-4.74	-0.78	-0.85	-2.86
Sale of Property, Plant & Equipment	-	0.05	-	-	-
Sale (Purchase) of Intangibles	-0.14	-0.17	-	-0.01	-0.02
Investment in Securities	-49.62	-488.54	33.7	19.9	55.5
Other Investing Activities	0.92	-1.09	0.66	-0.85	-0.33
Investing Cash Flow	-55.01	-494.5	33.58	18.2	52.29
Long-Term Debt Repaid	-10.29	-6.06	-6.37	-6.25	-4.47
Net Debt Issued (Repaid)	-10.29	-6.06	-6.37	-6.25	-4.47
Issuance of Common Stock	0	517.68	10.69	17.7	-
Repurchase of Common Stock	-43.02	-2.37	-	-	-
Common Dividends Paid	-41.27	-	-	-	-
Other Financing Activities	-	-0.11	-	-	0.11
Financing Cash Flow	-94.57	509.15	4.32	11.45	-4.36
Net Cash Flow	-38.67	34.31	6.29	-4.84	11.94
Free Cash Flow	104.74	14.91	-32.39	-35.33	-38.85
Free Cash Flow Growth	602.50%	-	-	-	-
Free Cash Flow Margin	50.67%	5.61%	-156.99%	-258.98%	-350.81%
Free Cash Flow Per Share	1.32	0.21	-0.58	-0.64	-0.72
Cash Interest Paid	-	0.12	0.18	0.26	0.26
Cash Income Tax Paid	-	0.09	-0.02	-0.06	-0.05
Levered Free Cash Flow	73.38	-24.67	-12.83	-12.85	-16.98
Unlevered Free Cash Flow	74.26	-24.59	-12.72	-12.7	-16.82
Change in Working Capital	24.9	-101.41	4.3	3.64	-0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.